Sanjay Gupta is Carter Kissell Associate Professor & Research Director in the Department of Urology at the Case Western Reserve University and University Hospitals Case Medical Center. He also holds secondary appointments in the Departments of Nutrition and Division of General Medical Sciences at Case Comprehensive Cancer Center. Dr Gupta obtained faculty position in 2002 at Case, School of Medicine.

Biomarkers of Prostate Cancer Chemoprevention of Prostate Cancer by Naturally Occurring or Synthetic Compounds Epigenetic Mechanisms of Gene Silencing in Prostate Cancer Identification and Characterization of Prostate Tumor Stem Cells Molecular Mechanisms of Prostate Cancer Molecular Targets of Prostate Cancer Prevention-based Clinical Trials with Promising Agents Role of Inflammation in Promoting Prostate Cancer Stem Cells as Therapeutics in Prostate Cancer

Dr Ali Is Certified in Surgery, thoracic Oncology and Thoracic Surgery. He received his advanced thoracic surgical education in Harvard Medical School, Boston USA at Brigham and Women's Hospital. Following that he completed an Advanced fellowship in minimally invasive Thoracic and Foregut surgery at Harvard Medical School. He was mentored by US leaders in their field of Thoracic Surgery who followed the tradition of pioneers in their fields, including Dr. Pearson in Toronto, Luketich in Pittsburgh, Orringer. He has closely worked with Dr Sugarbaker the late President of the American Association of Thoracic Surgery, Dr Scott Swanson a world leader in VATS surgery and Dr Steve Menzer, an expert in Lung surgery and Esophagectomy in North America.

His main interest include lung cancer, esophageal surgery, video-assisted thoracic surgery (VATS), GERD, hiatal hernia, lung transplantation, minimally invasive visceral cancer surgery and thoracic oncology. Dr Ali is a Fellow member of the Royal Australasian & American College of Surgeons, Society of Thoracic Surgery, Member of the Society of Surgical Oncology, Member of The American Gastrointestinal and Endoscopic Surgeons and Member of the Society for the Surgery of the Alimentary tract. His principal professional goal is the welfare of patients with thoracic , lung cancer and upper GI disease and malignancies. His main interest is in minimally invasive surgery and robotics to provide faster and smother recovery for his patients.

Professor Michael Silbermann (D.M.D) PhD and certified specialist in oral and maxilla‐facial surgery served for over 20 years as the Head of the Laboratory for Musculoskeletal Research. He then served as the Chairman of the Department of Anatomy and Cell Biology, Faculty of Medicine; Dean of the Faculty of Medicine, Technion; Chief Scientist, Ministry of Health; Chairman of the Board of Governors, the United States‐Israel Binational Science Foundation; Member of the Committee for the Promotion of Infrastructure in Biomedical Research, Ministry of Science, State of Israel; Member of the Foulkes Foundation (United Kingdom) Committee for Doctoral Fellowships; The Isreal Academy of Sciences and Humanities; Member of the National Committee for Ethics in Science and Intellectual Property, Israel; Executive Director, the Middle East Cancer Consortium since its establishment in 1996; First Representative of the State of Israel in the European Commission in the Program Committee of Bio‐Medical Research; EU, Brussels; Chairman, National Committee for Examining Academic Specialty Training in Health, Social and Education Professionals, The Council for Higher Education, State of Israel; Excellence in Biomaterials and Tissue Engineering, The Finnish Academy of Sciences, Helsinki, Finland.

Professor Michael Silbermann (D.M.D) PhD and certified specialist in oral and maxilla‐facial surgery served for over 20 years as the Head of the Laboratory for Musculoskeletal Research. He then served as the Chairman of the Department of Anatomy and Cell Biology, Faculty of Medicine; Dean of the Faculty of Medicine, Technion; Chief Scientist, Ministry of Health; Chairman of the Board of Governors, the United States‐Israel Binational Science Foundation; Member of the Committee for the Promotion of Infrastructure in Biomedical Research, Ministry of Science, State of Israel; Member of the Foulkes Foundation (United Kingdom) Committee for Doctoral Fellowships; The Isreal Academy of Sciences and Humanities; Member of the National Committee for Ethics in Science and Intellectual Property, Israel; Executive Director, the Middle East Cancer Consortium since its establishment in 1996; First Representative of the State of Israel in the European Commission in the Program Committee of Bio‐Medical Research; EU, Brussels; Chairman, National Committee for Examining Academic Specialty Training in Health, Social and Education Professionals, The Council for Higher Education, State of Israel; Excellence in Biomaterials and Tissue Engineering, The Finnish Academy of Sciences, Helsinki, Finland.

Rajvir Dahiya received his PhD in the field of Experimental Medicine and Biochemistry from the Post Graduate Institute of Medical Education and Research in Chandigarh, India. He completed four years of post-doctoral fellowship training in oncology and molecular biology at the University of Chicago Pritzker School of Medicine in Chicago, IL. Dahiya joined the University of California, San Francisco (UCSF) School of Medicine in 1987 as a scientist located at the San Francisco Veterans Affairs Medical Center (VAMC). He became director of the UCSF/VAMC Urology Research Center in 1991.

prostate cancer

Maurizio Chiriva-Internati completed his Doctorates in Immunology at the University of Nottingham, UK and Morphological Sciences at the University of Milan, Italy. He completed his Postdoctoral research on tumor immunology and cancer vaccine studies from the University of Arkansas for Medical Sciences. Currently, he is the Director of Basic and Translational Research at the division on Hematology & Oncology at the Texas Tech University Health Sciences Center, School of Medicine, and is a senior editor for the Journal, International Reviews of Immunology. He has published more than 100 papers in peer-reviewed journals and serves as on the Editorial Board of several journals.

antigens as therapeutic and diagnostic tools,novel cancer testis antigens for the development of immunotherapeutic strategies against solid and non-solid tumors,new therapies for multiple myeloma, ovarian and lung cancer, and prostate cancer and melanoma

Dr. P. K. Goyal is serving as Professor & Head in Department of Zoology, Chief of Radiation & Cancer Biology and Coordinator of DST -PURSE program, UGC-CAS program & PG Course of Microbiology at the University of Rajasthan, Jaipur. He has served as Director, PG School of Life Sciences during the period 2011-2014. He is honored as the President of Indian Society of Radiation Biology (ISRB) and President of Indo Global Health Care Research Foundation (IGHCRF). Dr. Goyal has 33 years teaching and research experience. He is the Member of Advisory Committee of Getting to know cancer, a Canadian based organization, for phytochemical research on Cancer management, and Councilor of Asian Congress on Radiation Research (ACRR), Japan. In recognition for his valuable and significant contribution in radiation and cancer research, he has been the recipient of several prestigious International/National awards such as Yuva Ratana Award (1985), TOYP Award (1986), ICRR Non-Tenured Scientist Award, Ireland (1999), ISHEER Award (2001), Shiksha Rattan Puruskar (2007), Samaj Rattan Puruskar (2008), Rastriya Gaurav Award (2009), Excellence Research Award (2010), Bharat Jyoti Award (2011) and Life Time Achievement Award (2012).

Dr Goyal’s group has been investigating the extracts of various medicinal plants e.g. Emblica officinalis (Amla), Rosemary officinalis (Rosemary), Alstonia scholaris (Sapthaparna), Aegle marmelos (Bael), Phyllanthus niruri (Bhumi amla), Syzgium cumini (Jamun), Tinospora cordifolia (Gloe), Averroa carambola (Kamrak) in various mouse models for the prevention and treatment of skin, stomach and liver cancers. It has been found that most of these plant extract have prophylactic potential in reducing the incidence of cancer and delaying the appearance of tumors. These results have been published in various national & International peer reviewed journals as well as presented in several international conferences. Investigations are ongoing to find out the active constituents / single molecule for the use in clinics for the cancer management.

Mahmoud El-Foudeh is currently working as Consultant in Oncology and Palliative Medicine at Oncology Center, King Faisal Specialist Hospital and Research Center. He completed his MBBS, from Alexandria University; Egypt and obtained his Master in Clinical Oncology from London University, UK.. Mahmoud El-Foudeh is having experience in the field of clinical oncology for more than 20 years, mainly in the specialty of medical oncology and last in the Palliative Care Medicine. He trained and practiced oncology and Palliative medicine in different major international Cancer Institutions including Gustav-Rosy and Centre Leon Berard in France, and the Royal Marsden Hospital in UK, and participated in several clinical cancer-related trials, national and international Cancer and Palliative oncology-related presentations. Also he worked as Author and co-other of numerous oncology publications in reputable international cancer journals.

In the field of clinical oncology mainly in the field of medical oncology and in the Palliative Care Medicine

Sadir Al Rawi currently is the chief of surgical oncology division at Tawam Hospital and is the interim chair of department of surgery since October 2013. Tawam Hospital is affiliated with JOHN HOPKINS. Prior to that, Alrawi was an assistant professor in the Department of Surgery/Division of Surgical Oncology at University of Florida, Jacksonville. He trained in various Academic institutes in Surgical Oncology all over including Roswell Park, Cancer institute, Buffalo, Royal Free Hospital, UC of London and Ninewells Hospital, Dundee, United Kingdom. Sadir Al Rawi is American board certified, completed his Head & Neck fellowship and Surgical Oncology fellowship at Roswell Park Cancer institute (NCI) designated in 2006. Dr Alrawi did advanced Laparoscpic oncology training with Professor Alfred Cuschieri in Dundee 1992-1993, advanced colorectal oncology training with E Lloyd Davis in Cornwall, England 1993-1995 and advanced surgical oncology with Professor Marc Winslett, London 1995-1996.

Dr Alrawi major interest is Gastrointestinal Oncology, including Esophageal, Gastric, Pancreas, Liver and colonic surgery with special interest in endocrine surgery including thyroid , parathyroid and adrenal surgery,

Dr. Sudeep Gupta is a Professor of Medical Oncology at Tata Memorial Hospital in Mumbai, India. Dr. Gupta obtained his MBBS degree from All India Institute of Medical Sciences (AIIMS) in New Delhi in 1992. He completed his Postgraduate (MD degree) in internal medicine in 1994 and his Medical Oncology training in 2000 at the same Institute. Following his Medical Oncology training, Dr. Gupta joined Tata Memorial hospital in Mumbai as an Assistant Professor in Medical Oncology and was promoted to Associate Professor in 2003 and Professor in 2010.

Dr. Gupta is an outstanding researcher and has special interests in breast cancer and gynecological malignancies and early drug development. In breast cancer Dr. Gupta’s areas of research include adjuvant therapy and management approach of metastasis from breast cancer. His other areas of research are cervical cancer, ovarian cancer, multiple myeloma and lymphoma.

Fellow of the American college of Physician (FACP). Lebanese board of hematology/Oncology (AUBMC). European certification in Medical Oncology

hematology/Oncology

Dr. Tam Truong Donnelly is a Full Professor at the University of Calgary, Alberta, Canada and Associate Dean for Research at the University of Calgary-Qatar. In Canada, Dr. Donnelly’s research studies were funded by the National Cancer Institute of Canada (NCIC) and the Canadian Institutes of Health Research (CIHR). In Canada, Dr. Donnelly’s research focuses on the Health and Wellness of Immigrants and Refugees which include breast cancer and cervical cancer screening practices, HIV/AIDS, mental healthcare, and support for international nursing students. In 2005, Dr. Donnelly received the Alberta Centennial Medallion Award in recognition for her works with immigrant populations. In Qatar, funded by the Qatar National Research Fund, (NPRP and UREP programs), Dr. Donnelly’s research focuses on Arab women’s breast cancer screening, depression among cardiovascular patients, lifestyle risk factors that contribute to chronic diseases, and promotion of healthy lifestyle among Arabic speaking adults.

Fostering active living, Depression in CV patients, Breast cancer screening, Qatar,Breastfeeding practices,Life style behaviours,Breastfeeding decisions,HIV/AIDS and immigrants, Immigrants' mental health, Vietnamese breast/cervical cancer screening